LINC02362

Across TCGA pan-cancer cohorts, LINC02362 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC02362’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02362 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02362 is over-expressed in tumor, although a few such as COAD and LIHC show the opposite, repressed pattern.

COAD, LUAD, and KIRC are the cancer types where LINC02362 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02362 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−1.331	<.001	11	view →
LUAD	Female	All	+1.232	<.001	9	view →
KIRC	Male	II,III,IV	+0.439	<.001	9	view →
LIHC	Female	All	−1.668	<.001	6	view →
BRCA	Female	All	−0.222	.014	6	view →
CHOL	Male	All	−3.474	<.001	5	view →
LUSC	All	All	+0.624	<.001	5	view →
READ	All	All	−0.983	.003	2	view →
HNSC	All	III,IV	+0.382	.013	2	view →
KICH	All	IV	+0.229	.030	2	view →
ESCA	All	All	+0.789	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC02362–COAD

Open the COAD breakdown →